
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aytu BioPharma is a pharmaceutical company focused on commercializing novel therapeutics. The company's prescription products include Adzenys XR-ODT(R) (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT(R) (met... Aytu BioPharma is a pharmaceutical company focused on commercializing novel therapeutics. The company's prescription products include Adzenys XR-ODT(R) (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT(R) (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), Karbinal(R) ER (carbinoxamine maleate), an extended-release antihistamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor(R) and Tri-Vi-Flor(R), two complementary fluoride-based prescription vitamin product lines available in various formulations for infants and children with fluoride deficiency. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.41 | 26.6233766234 | 1.54 | 2.2692 | 1.5 | 2000610 | 2.00673328 | CS |
4 | -0.28 | -12.5560538117 | 2.23 | 2.46 | 1.46 | 871908 | 2.00696847 | CS |
12 | 0.64 | 48.8549618321 | 1.31 | 2.7 | 0.95 | 1421210 | 2.39040872 | CS |
26 | 0.45 | 30 | 1.5 | 2.7 | 0.95 | 704825 | 2.36711623 | CS |
52 | -1.14 | -36.8932038835 | 3.09 | 3.16 | 0.95 | 361980 | 2.35965309 | CS |
156 | -8.05 | -80.5 | 10 | 16.194 | 0.95 | 364720 | 4.23253765 | CS |
260 | -27.05 | -93.275862069 | 29 | 235.286 | 0.95 | 847857 | 35.28067303 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions